Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank89
3Y CAGR+133.2%
5Y CAGR+32.9%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+133.2%/yr
vs -15.8%/yr prior
5Y CAGR
+32.9%/yr
Recent acceleration
Acceleration
+149.1pp
Accelerating
Percentile
P89
Within normal range
vs 5Y Ago
4.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.60M | -7.7% |
| 2024 | $16.89M | +265.8% |
| 2023 | $4.62M | +275.8% |
| 2022 | $1.23M | +5443.5% |
| 2021 | $-23000.00 | -100.6% |
| 2020 | $3.77M | -39.3% |
| 2019 | $6.20M | +153.3% |
| 2018 | $2.45M | +937.3% |
| 2017 | $236000.00 | +244.8% |
| 2016 | $-163000.00 | - |